Previous research has found that low-intensity ultrasound enhanced the lethal effect of gentamicin on planktonic E. coli. We aimed to further investigate whether microbubble-mediated low-intensity ultrasound could further enhance the antimicrobial efficacy of gentamicin. The planktonic E. coli (ATCC 25922) was distributed to four different interventions: control (GCON), microbubble only (GMB), ultrasound only (GUS), and microbubble-mediated ultrasound (GMUS). Ultrasound was applied with 100 mW/cm(2) (average intensity) and 46.5 KHz, which presented no bactericidal activity. After 12 h, plate counting was used to estimate the number of bacteria, and bacterial micromorphology was observed with transmission electron microscope. The results showed that the viable counts of E. coli in GMUS were decreased by 1.01 to 1.42 log10 CFU/mL compared with GUS (P < 0.01). The minimal inhibitory concentration (MIC) of gentamicin against E. coli was 1 μ g/mL in the GMUS and GUS groups, lower than that in the GCON and GMB groups (2 μ g/mL). Transmission electron microscopy (TEM) images exhibited more destruction and higher thickness of bacterial cell membranes in the GMUS than those in other groups. The reason might be the increased permeability of cell membranes for gentamicin caused by acoustic cavitation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052079 | PMC |
| http://dx.doi.org/10.1155/2014/142168 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Innovative Methodology for Antimicrobial Susceptibility Determination in Biofilms.
Microorganisms
December 2024
Department of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59718, USA.
spp. are facultative pathogens that contribute to the pathogenesis of multiple bovine diseases, including the bovine respiratory disease complex, and have been shown to form biofilms. Biofilm formation is associated with increased antibiotic resistance in many organisms, but accurate determination of antimicrobial susceptibility in biofilms is challenging.
View Article and Find Full Text PDFTime-Kill Curve Analysis of Fucoidan Combination with Conventional Antibiotics against Biofilms Formation of Methicillin-Resistant Staphylococcus aureus and Acinetobacter baumannii Clinical Isolates.
Chemotherapy
December 2024
Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Article Synopsis
- - This study explores how fucoidan, a natural polysaccharide, works alone and with antibiotics against biofilms formed by Methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii, particularly in cases related to diabetic foot ulcers (DFUs).
- - The results showed that using fucoidan with antibiotics like gentamicin and imipenem significantly enhances antimicrobial effectiveness, especially in mixed-species biofilms, with low toxicity to human skin cells.
- - The findings suggest that fucoidan could be a promising treatment to disrupt harmful biofilms in DFU patients, indicating the need for more clinical research in this area.
The antimicrobial and antibiofilm effects of gentamicin, imipenem, and fucoidan combinations against dual-species biofilms of Staphylococcus aureus and Acinetobacter baumannii isolated from diabetic foot ulcers.
Ann Clin Microbiol Antimicrob
November 2024
Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Introduction: Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to impaired insulin production or utilization, leading to severe health complications. Diabetic foot ulcers (DFUs) represent a major complication, often exacerbated by polymicrobial infections involving Staphylococcus aureus and Acinetobacter baumannii. These pathogens, notorious for their resistance to antibiotics, complicate treatment efforts, especially due to biofilm formation, which enhances bacterial survival and resistance.
View Article and Find Full Text PDFA Cell-Based Screening Assay for rRNA-Targeted Drug Discovery.
ACS Infect Dis
December 2024
Laboratory of Medicinal Chemistry, Department of Chemistry, Clemson University, Clemson, South Carolina 29634, United States.
Worldwide, bacterial antibiotic resistance continues to outpace the level of drug development. One way to counteract this threat to society is to identify novel ways to rapidly screen and identify drug candidates in living cells. Developing fluorescent antibiotics that can enter microorganisms and be displaced by potential antimicrobial compounds is an important but challenging endeavor due to the difficulty in entering bacterial cells.
View Article and Find Full Text PDFAntimicrobial and antibiofilm activity of human recombinant H1 histones against bacterial infections.
mSystems
November 2024
Bacterial infections and antimicrobial therapies group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Article Synopsis
- Histones have antimicrobial properties, particularly against biofilms, but their clinical use can be limited due to concerns about toxicity.
- The study found that human recombinant histone H1 subtypes, particularly H1.0 and H1.4, effectively reduced PAO1 bacteria, with H1.4 showing potential to disrupt biofilm formation while being non-toxic to larvae.
- The research highlights histones as promising alternatives in fighting infections by multidrug-resistant bacteria, especially in combination with existing antibiotics like ciprofloxacin, despite some limitations in improving effectiveness.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!